Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
360 participants
INTERVENTIONAL
2021-10-06
2023-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The change in prescription pattern from before to after the visit is compared between the intervention and control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Multi-faceted Intervention Combining an Educational Outreach Visit to General Practitioners and Patient Education Material to Deprescribe Proton Pump Inhibitors (PPI): a Population-based, Pragmatic, Cluster-randomized Controlled Trial
NCT04513834
Optimisation of Nutrition and Medication for Acutely Admitted Older Medical Patients
NCT03741283
Efficacy of a Multi-faceted Intervention to Deprescribe Proton Pump Inhibitors (PPI) in Primary Care: a Population-based, Pragmatic, Cluster-randomized Controlled Trial.
NCT04255823
Tailored Intervention to Improve Medication Adherence in Patients With Hypertension
NCT01742923
Prioritising Patient Medication Review: Hospitals Reaching Out
NCT06451692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The prescription pattern of each general practice (as seen by their regional registration number \[ydernummer\]) who receive a visit is investigated.
The change in prescription pattern from before to after the visit is compared between the intervention and control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Proton pump inhibitor education
The general practices in this arm will receive the education visits about Proton pump inhibitor.
Proton pump inhibitor education
A 15 minutes (preferable) one-on-one educational visit about deprescription of proton pump inhibitor
Other education
The general practices in this arm will receive an educational visit on another topic (asthma).
Other education
A 15 minutes (preferable) one-on-one educational visit about another topic (NOT asthma).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proton pump inhibitor education
A 15 minutes (preferable) one-on-one educational visit about deprescription of proton pump inhibitor
Other education
A 15 minutes (preferable) one-on-one educational visit about another topic (NOT asthma).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Want a visit
* Have time for a visit within the study period
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jón Þór Trærup Andersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jón Þór Trærup Andersen
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jon tt Andersen, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Bispebjerg and Frederiksberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Bispebjerg and Frederiksberg
Copenhagen, Capital Region of Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
jon tt Andersen, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-2021-709b
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.